By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Genmab A/S 

Toldbodgade 33

Copenhagen    K-1253  Denmark
Phone: 45-7020-2728 Fax: 45-7020-2729


SEARCH JOBS


Key Statistics


Email:
Ownership: Public

Web Site: Genmab A/S
Employees:
Symbol: GEN.CO
 



Industry
Biotechnology


Collaborations

Bionomics Limited  Anti-angiogenesis therapeutic antibody development





Company News
Genmab A/S (GEN.CO) Announces Start Of Rolling Submission Of Biologics License Application For Daratumumab For Double Refractory Multiple Myeloma To The FDA 6/8/2015 7:26:46 AM
Genmab A/S (GEN.CO) Gains License To Antibody Panel Targeting CD19 6/2/2015 7:22:33 AM
Genmab A/S (GEN.CO) Release: Ofatumumab And Daratumumab Data To Be Presented At 20th Congress Of European Hematology Association 5/21/2015 2:14:24 PM
BioNTech, Genmab A/S (GEN.CO) Forge $15 Million Immuno-Oncology Pact 5/19/2015 6:02:27 AM
Genmab A/S (GEN.CO) Achieves USD 10 Million Milestone In Daratumumab Collaboration With Janssen Biotech Inc. (JNJ) 4/17/2015 8:00:32 AM
Genmab A/S (GEN.CO) Acquires Antibody Assets From iDD Biotech 3/18/2015 9:46:11 AM
Capital Increase In Genmab A/S (GEN.CO) As A Result Of Employee Warrant Exercise And Projection Of Improved Cash Position At The End Of 2015 3/12/2015 7:23:55 AM
Genmab A/S (GEN.CO) Announces That Agreement To Transfer Ofatumumab Collaboration To Novartis AG (NVS) Is Now Effective 3/2/2015 7:20:14 AM
Bionovion Enters Commercial Immune Oncology Collaboration With Genmab A/S (GEN.CO) 2/19/2015 10:55:15 AM
Genmab A/S (GEN.CO) Release: Major Shareholder Announcement 2/5/2015 7:57:34 AM
12345678910...
//-->